ArticleThe Journal of clinical investigation2026
The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1.
Xiuxian Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.